Jobs / United States / Astrazeneca Pharmaceuticals Lp
【AstraZeneca】【R&D】Clinical Site Lead (BioPharma), Site Management & Monitoring Group, BioPharma Clinical Operations, Development Operations
Astrazeneca Pharmaceuticals Lp · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Associate Director, Oncology Portfolio Analytics” (Management Analysts) in MD: $157k–$157k, median $157k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
■ 職務内容 / Job Description Clinical Site Lead (CSL) is a field-based role within Site Management & Monitoring (SMM) at AstraZeneca K.K., dedicated to supporting clinical trials within Japan. The CSL will be assigned to dedicated disease area and proactively drive site performance, enhance site engagement, and foster strong relationships with investigators and site staff based on enhancing knowledge at the specific disease area. The CSL will focus on driving recruitment performance and ensuring strong CRO oversight, without direct site management and monitoring responsibilities. This role will contribute to operational feasibility assessments and provide input on recruitment and retention strategies as well. ■ Key Responsibilities •Planning: Contribute to the accurate site and recruitment plan •Partnerships: Establish strategic partnership models and frameworks for deployment across key clinical sites and investigators. •Communication: Maintain awareness of market activities, policies, trends, technologies, and information affecting the business, to support the ongoing improvement of clinical recruitment efforts in line with company policies •Strategic Input: Provide SMM input to clinical study documents, including Clinical Study Protocol (CSP), Informed Consent Form (ICF), and Monitoring Plan. •Performance Monitoring: Monitor study progress, including country start-up, site activation, and recruitment •Risk Management: Track study performance and delivery risks, and work alongside LST and GST to develop and implement mitigation plans. •When the CSL is assigned to induvial clinical study, having full responsibility for the site and study management from AZ KK, the CSL will take following responsibilities. •Lead and manage all activities related to site management and monitoring including the following with agreed timelines and company standard quality in Japan. •Plan and deliver a site selection strategy •Plan patient recruitment strategy including SMO managements and following patient recruitment progress •Lead and manage CRAs including CRO CRAs to deliver clinical study data •Develop and manage risk mitigation plans and contingency plans to execute site managements and monitoring from site qualification to site close on time. •Lead and manage the quality of clinical study data. •Lead and manage queries and quality issues related to site management and monitoring together with CRAs. •Contribute to regulatory inspection in the area of site management and monitoring from study set up through conduct and inspection readiness. •Escalate issues related to site management and monitoring to an appropriate person and contribute to resolve. •Lead certain number of CRAs (incl. CRO CRAs) to in terms of information management and communication related to site management in study team to keep monitoring quality. •Contribute to the development of Development Operations Japan by joining some projects or initiatives, e.g. Process Ownership responsibilities, CRA training. •Contribute or encourage to innovate clinical trial environment with new technologies which AZ will implement, cooperating with study sites and sites’ staff. ■ 応募資格（経験、資格等）/ Qualification (Experience & Skill etc.) 【経験 / Experience】 ＜必須 / Mandatory＞ •At least 3-years’ experience in pharmaceutical industries or clinical research organization, preferably in Clinical Operations (CRA, Senior CRA) •Demonstrated leadership capability in a team environment successfully. •Negotiated some complicated issues and/or requirements with site staff. •Team oriented and flexible; ability to respond quickly to shifting demands and opportunities. ＜歓迎 / Nice to have＞ • Preferred experience to collaborate with external partners. • Performed monitoring activities from qualification vis